Nov 2026· Open Forum Infectious Diseases· 0 citations
TL;DR
The estimated incidence and proportion positive of RSV disease in EMC is substantially lower than HIC, and narrow case definitions requiring fever, less sensitive testing such as direct fluorescent antibody testing, reduced healthcare access, and incomplete surveillance may be contributing to these lower estimates.
Abstract
Most previous studies on adult respiratory syncytial virus (RSV) burden focus on high-income settings (HIC). With the recent approval of RSV vaccines for adults, extending epidemiological understanding to emerging market countries (EMC) is critical for informing prevention strategies. We aimed to characterize the burden of RSV among adults ≥18 years in EMC.
We conducted a systematic review (PROSEPRO: CRD420251137828) to identify studies reporting estimates of RSV burden from any care setting in adults>18 years in EMC. For each individual study included, we followed a two-step statistical approach to adjust for RSV case under-ascertainment related to the use of clinical specimen and diagnostic test. Random-effects meta-analysis was conducted to estimate RSV incidence rate, proportion positive, hospitalisation, and mortality burden.
We included 70 studies of which the majority were from China (30/70) and PCR was the predominant diagnostic method (59/70). Adjusted RSV disease incidence rate (approximately 2.5 times higher than unadjusted) ranged from 2,544 (95% CI 1,352-4,787) per 100,000 in adults aged 18-49 years to 2,392 (1,618-3,534) in adults ≥65 years after accounting for clinical sampling and diagnostic testing. Adjusted hospitalisation rates increased with age, from 20 (8-51) per 100,000 in 18-49 years to 74 (3-2,027) in adults ≥65 years, representing an approximate 2.5-fold increase after adjustment. The adjusted RSV proportion positive was relatively stable, ranging from 1.8% (0.4-8.5) to 9.7% (6.3-14.6), regardless of settings or clinical case definitions. The unadjusted in-hospital case fatality ratio (hCFR) was 6.0% (2.9-11.9) in adults ≥65 years vs 3.1 (2.0-5.0) in those 18-49 years. Among hospitalized RSV-positive adults, 95.8% (84.2-99.0) had at least one comorbidity, most commonly hypertension, diabetes, and COPD.
The estimated incidence and proportion positive of RSV disease in EMC is substantially lower than HIC. Narrow case definitions requiring fever, less sensitive testing such as direct fluorescent antibody testing, reduced healthcare access, and incomplete surveillance may be contributing to these lower estimates. In-hospital CFR are comparable to or higher than in HIC.
It is shown that RSV causes substantial burden in primary care and emergency departments, particularly among infants, but that reported incidence estimates vary widely due to differences in study design, case definitions, age groups and testing practices, and by applying a multilevel meta-analysis, this thesis generate...
Background: Respiratory syncytial virus (RSV) is a major cause of acute respiratory infections among older adults and individuals with chronic medical conditions. Recently developed RSV vaccines have demonstrated clinical efficacy, but their economic value remains unclear across different healthcare settings and target...
Lukman Aryoseto, H. A. Haq, M. Madani et al.· Biomedical & Pharmacolog...· 0 citations
ABSTRACT Background Respiratory syncytial virus (RSV) is among the leading causes of lower respiratory tract illness in newborns worldwide. This study reviews evidence on the efficacy and safety of maternal RSV vaccination. Methods PROSPERO registered this PRISMA-compliant systematic review (CRD42024566335). Keywords a...
Khawla Abu Hammour, Qusai Manaseer, Murad Dweik et al.· Journal of Pharmaceutical Po...· 0 citations
Background Respiratory syncytial virus (RSV) infects nearly all children under two years, causing mild lower respiratory tract infections (LRTIs) although serious disease, mortality and long-term recurrent wheezing can also occur. Objectives This study evaluates the health and economic impact of various RSV prevention...
K. Kura, C. Burgess, Ian R. Matthews et al.· Therapeutic Advances in Infe...· 0 citations
INTRODUCTION
Respiratory syncytial virus (RSV) can cause serious disease in older adults (OAs), particularly those with underlying medical conditions. It can lead to acute respiratory illness and lower respiratory tract infections in adults ≥60 years and at increased risk groups. RSV morbidity, mortality, and health ca...
Otávio Cintra, Abhay Phansalkar, M. Laucho-Contreras et al.· Expert Review of Vaccines· 1 citation
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in young children. In 2019, RSV was estimated to cause approximately 33 million acute lower respiratory infections, 3.6 million hospitalisations and more than 101,000 deaths among children under five years of age, with more than...
N. Rave· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.